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ABSTRACT
mRNA splicing and export plays a key role in the
regulation of gene expression, with recent evidence
suggesting an additional layer of regulation of gene
expression and cellular function through the selec-
tive splicing and export of genes within specific
pathways. Here we describe a role for the RNA pro-
cessing factors THRAP3 and BCLAF1 in the regu-
lation of the cellular DNA damage response (DDR)
pathway, a key pathway involved in the maintenance
of genomic stability and the prevention of onco-
genic transformation. We show that loss of THRAP3
and/or BCLAF1 leads to sensitivity to DNA damag-
ing agents, defective DNA repair and genomic insta-
bility. Additionally, we demonstrate that this pheno-
type can be at least partially explained by the role of
THRAP3 and BCLAF1 in the selective mRNA splic-
ing and export of transcripts encoding key DDR pro-
teins, including the ATM kinase. Moreover, we show
that cancer associated mutations within THRAP3 re-
sult in deregulated processing of THRAP3/BCLAF1-
regulated transcripts and consequently defective
DNA repair. Taken together, these results suggest
that THRAP3 and BCLAF1 mutant tumors may be
promising targets for DNA damaging chemotherapy.
INTRODUCTION
RNA processing and its further translation are compart-
mentalized processes occurring in the nucleus and cyto-
plasm respectively. Pre-mRNA synthesis and maturation
occurs through amulti-step process involving transcription,
addition of a 5′ methyl-guanine (m7G) cap, removal of in-
tronic sequences by splicing and cleavage of the 3′ end fol-
lowed by polyadenylation (1), thus leading to the produc-
tion of a stable mature RNA and facilitating its export
from the nucleus for further translation (2,3). Each step
involves engagement with different sets of RNA-binding
proteins (RBPs), hnRNPs and SRs, which co-ordinate to
yield a mature mRNA and transport it to the ribosome
for translation and subsequent protein expression (4,5).
Moreover, additional layers of complexity are introduced
through the mechanistic coupling of transcription to cap-
ping, 3′ end processing to splicing and splicing to ex-
port. For example, the mammalian capping enzyme (com-
prised of RNA 5′-triphosphatase, guanylyl-transferase and
(guanine-N7) methyltransferase) binds to the phosphory-
lated C-terminal domain of RNA polymerase II allow-
ing the latter to proceed to the transcription elongation
step (6); the nuclear protein ALY is recruited to mRNAs
during splicing, through interaction with the spliceosome
component UAP56, thus leading to successful mRNA ex-
port (7,8). Indeed, the coupling of each successive step
within the RNA synthesis/maturation pathway may serve
as an additional level of control of gene expression. Re-
cent evidence also suggests multiple levels of selectivity in
both mRNA splicing and export with multiple cellular pro-
cesses controlled by selective splicing and export, includ-
ing maintenance of pluripotency, stress responses, prolifer-
ation, survival/apoptosis, haematopoiesis and DNA repair
(9–11). Indeed, a recent study investigating the impact of SR
proteins on mRNA splicing found that the serine arginine
rich (SR) mRNA-splicing proteins SRSF1–SRSF7, both
contribute to themRNA splicing of distinct groups of genes
(with each SRSFprotein regulating different pools of genes)
and also couple this selective splicing to selective mRNA
export, by acting as adaptor proteins allowing the bind-
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ing of the mRNA export factor NXF1 to target transcripts
(11). Additionally, specific genes have also been shown to
be regulated at the mRNA splicing and export levels follow-
ing specific stimuli. In particular, the involvement of RNA
splicing and export factors (SFs) within the cellular DNA
damage response (DDR) pathway is now becoming evident
(12,13).
In keeping with this, a novel BRCA1-interacting RNA
splicing complex, containing many members of the core
RNA splicing machinery such as BCLAF1, THRAP3 and
SF3B1, has been recently identified by our group (14). This
complex is formed in response toDNAdamage through the
ATM-dependent phosphorylation of BRCA1, which is con-
stitutively bound to the promoters of a large subset of genes.
Formation of this complex on genetic promoters bound
by BRCA1, promotes their pre-mRNA splicing and subse-
quent transcript stability in response to DNA damage. One
particular member of this complex, THRAP3, has been
shown to be phosphorylated at five different serine residues,
in an ATR kinase-dependent manner, in response to differ-
entDNAdamaging agents, as well as PARylated in response
to oxidative stress, which further facilitates its localization
to nuclear speckles along with other splicing factors (15,16).
Moreover, THRAP3 depletion sensitizes cells to the repli-
cation inhibitor hydroxyurea (HU), suggesting a function
for THRAP3 in the DDR (15). Importantly, THRAP3 de-
ficiency has been observed in multiple cancer types, such as
breast and ovarian cancers, oral squamous cell carcinomas,
liver tumors and parathyroid carcinomas, suggesting that it
may function as a tumor suppressor gene, possibly through
a role in the DDR (17–19).
Despite the regulation of THRAP3 in response to DNA
damage, here we report a new function for THRAP3 and
BCLAF1 in RNA splicing and export independent of
DNA damage and their role in the BRCA1/BCLAF1 com-
plex. More specifically, our study shows that, together with
BCLAF1, THRAP3 selectively regulates the constitutive
mRNA splicing and export of a specific subset of tran-
scripts, many of which are involved in the cellular DDR.
Moreover, we demonstrate that BCLAF1 is able to par-
tially compensate for the absence of THRAP3 and vice
versa, with double knockdown of both factors leading to
severe cellular sensitivity to DNA damage and DNA re-
pair deficiency. We also show that this sensitivity to DNA
damaging agents can be at least partially explained by the
involvement of THRAP3 and BCLAF1 in the process-
ing of transcripts encoding members of the FA/BRCA-
related DNA repair pathway, including ATM. Specifically,
we found that BCLAF1 promotes the splicing of these tran-
scripts, whilst THRAP3 promotes their export to the cy-
toplasm, both tightly linked processes required for tran-
script stability and protein expression. Finally, we show that
cancer-associated mutations identified within THRAP3 in-
duce a severe defect in DNA double strand break (DSB)
repair capability. Thus, our results suggest that tumors har-
boring mutations within THRAP3 may be promising tar-
gets for DNA damaging therapies.
MATERIALS AND METHODS
Cell lines
293T and U2OS cells were obtained from the Cancer Re-
search UK cell Repository (London Research Institute,
London). U2OS-DR-GFP cells were a kind gift from Prof
Jeremy Stark (Beckman Research Institute of the City of
Hope, Duarte, CA, USA). All cell lines were maintained
in Dulbecco’s modified Eagle’s medium media (Sigma-
Aldrich) containing 10% fetal calf serum. Additionally, all
cells used in this study were thawed directly from short tan-
dem repeat (STR) profiled stocks to ensure their validity.
siRNAs
siRNAs with the following sequences were obtained from
QIAGEN; siBRCA1: 5′- ACC ATA CAG CTT CAT
AAATAA -3′, siBCLAF1 2: 5′CUA GAU UAC UUC
AGU GAU ATT-3′ 5′, siBCLAF 4 5′-UAG UAG AGA
UCG UAUGUA UTT-3′ (siBCLAF1 contains 50% siB-
CLAF1 2 and 50% siBCLAF 4 siRNAs). siTHRAP3 7
5′- ACGAGTTGAATCATTGTTCAA -3′, siTHRAP3 8
5′- CCCGTTCTTCCTCCAACCATA -3′ (siTHRAP3 con-
tains 50% siTHRAP3 7 and 50% siTHRAP3 8 siRNAs).
siTHRAP3+siBCLAF1 contains 50% siBCLAF1 2/4 and
50% siTHRAP3 7/8 siRNAs. siRNA oligos were delivered
to a final concentration of 10nM by reverse transfection us-
ing RNAiMax (Invitrogen) according to manufacturer’s in-
structions with cells incubated for 48–72 h following trans-
fection (dependent on the length of the assay being carried
out).
Plasmids
pcDNA3.1(+)-THRAP3-FLAG, pcDNA3.1 (+)-
THRAP3-N190-FLAG, pcDNA3.1 (+)-THRAP3-
C359-FLAG and pcDNA3.1 (+)-THRAP3-NC-FLAG
plasmids were kindly provided by professor Woan-Yuh
Tarn, National Taiwan University, Taipei, Taiwan (20).
The pRFP2GFP-ATM construct was generated using the
pmaxGFP vector as a backbone. The RFP (red fluorescent
protein) sequence was amplified by polymerase chain reac-
tion (PCR) from pmTagRFP-T2-N1 (Michael Davidson
Lab via Addgene) using the following primer sequences:
Forward 5′-ATGGTGTCTAAGGGCGAAGAG-3′ and
Reverse 5′-GCGGTACCGTCGACTGCA-3′ plus 20 bp
of homology and HindIII and SalI sites in the reverse
primer. This PCR product was inserted into the pmaxGFP
vector upstream of the turbo-GFP (green fluorescent
protein) open reading frame (ORF) between the KpnI and
AgeI sites using Gibson assembly (NEB). The sequence
encoding the ATM exon20-intron20-exon21 was PCR
amplified from 293T derived genomic DNA using the
following primer sequences: Forward 5′- GTGAAGCT
TTCCAATGTGTGTTCTTTGTATC-3′ and Reverse 5′-
TACGTCGACCTCAAGCAAAGTTTTAAG-3′, and
cloned into the pRFP2GFP vector’s ORF between RFP
and GFP tags using novel HindIII and SalI sites. pCMV6-
AN-Myc-DDK was purchased from Origene (PS100016).
The ORF of THRAP3 was inserted in this plasmid using
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SgfI and MluI sites. THRAP3, cloned in this vector, was
expressed as the N-terminal Myc-DDK-tagged protein.
Site directed mutagenesis
The QuickChange Site Directed Mutagenesis kit (Strata-
gene) was used, as per the manufacturer’s instructions, to
introduce the C301>T and C2509>T substitutions within
the N-Myc-DDK-THRAP3 construct using the following
primers: THRAP3 C301T Forward 5′- CATGGGGCCA
ATATAACTGAGGAGGCTATGGAAAC -3′, THRAP3
C301T Reverse 5′- GTTTCCATAGCCTCCTCAGTTA
TATTGGCCCCATG -3′, THRAP3 C2509T Forward 5′-
GAACCT TTCAGTTTTGAGCCAGAGGAAGAG -3′,
THRAP3 C2509T Reverse 5′- CTCTTCCTCTGGCTCA
AAACTGAAAGGTTC -3′
Nuclear and cytoplasmic RNA fractionation
Cells were trypsinized and centrifuged at 300 g for 5 min.
The plasma membrane was then lysed with 175 l of RLN
buffer (50 mM Tris–HCl, pH 8.0, 140 mM NaCl, 1.5 mM
MgCl2, 0.5% (v/v) Nonidet P-40 (1.06 g/ml)) for 5 min on
ice. Lysate was then centrifuged for 2 min at 300 g. The su-
pernatant, containing cytoplasmic RNA, was transferred
to a new tube, whereas the remaining pellet was used for
obtaining nuclear RNA which was extracted using Qiagen
RNeasymini kit as per the manufacturer’s instructions. The
purity of cytoplasmic and nuclear RNA fractions was al-
ways checked by assessing the expression of the nuclear spe-
cific RNA MALAT1 via quantitative reverse transcriptase
(qRT)-PCR.
qRT-PCR and splicing analysis
A total of 1 g of DNAse (Invitrogen) treated RNA was
used for cDNA synthesis using the Transcriptor High
Fidelity cDNA Synthesis Kit (Roche Applied Science)
according to the manufacturer’s instructions. qRT-PCR
was performed using primers specific to each transcript or
to ACTB mRNA, on both RT positive and RT negative
generated cDNA. All reciprocal qRT-PCR reactions
performed on RT−ve cDNA were assessed for the ab-
sence of any cDNA amplification indicating no genomic
DNA contamination prior to further analysis of data.
All qRT-PCR reactions were carried out on a ROCHE
LightCycler 480 using SYBR Green 480 I Master Mix
(ROCHE) as per the manufacturer’s instructions. mRNA
concentration levels were then assessed using the ROCHE
Relative Quantification algorithm, utilizing in-run stan-
dard curve qRT-PCR data generated for each primer set
from a serially diluted RNA standard. For quantitative
splicing analysis, introns/exons were chosen for assessment
in splicing analysis based on their suitability for optimal
qRT-PCR primer design. Primers spanning exon-exon
boundaries (post-spliced) and exon-intron boundaries
(pre-spliced) were designed using the ROCHE universal
probe library and manually inputting exon-exon and
exon–intron flanking sequences. Using these primers (listed
below) levels of pre-spliced and post-spliced mRNAs were
assessed as above and normalized to ACTB expression
levels within the same samples. Primers used for qRT-PCR
analysis were as follows: MALAT1 Forward: 5′-GAC
GGAGGTTGAGATGAAGC-3′, MALAT1 Reverse:
5′-ATTCGGGGCTCTGTAGTCCT-3′, ACTB Forward:
5′-AGACCTGTACGCCAACACAG-3′, ACTB Reverse:
5′-GGAGCAATGATCTTGATCTTCA-3′, THRAP3 For
ward: 5′-GCCGATCTCTCTCTCGTCA-3′, THRAP3 R
everse: 5′-TTGGGTGGTTTCTTTCTCTGTTA-3′, BCL
AF1 Forward: 5′-CGACCACGAGGAACCTTTT-3′, B
CLAF1 Reverse: 5′-TTTGTCCCAGCAAAAACTCC-3′,
ATM Exon20 Forward: 5′-TTTCTTACAGTAATTGG
AGCATTTTG-3′, ATM Exon21 Reverse: 5′-GGCAA
TTTACTAGGGCCATTC-3′, ATM Intron20 Reverse:
5′-CAAGCGACTGAGGGAAACAC-3′, FANCD2 Exo
n36 Forward: 5′-CCCAGAACTGATCAACTCTCCT-3′,
FANCD2 Exon37 Reverse: 5′-CCATCATCACACGGA
AGAAA-3′, FANCD2 Intron37 Reverse: 5′-ACAGG
TGTGTGCCACCGTG-3′, BRCA2 Exon18 Forward:
5′-CCTGATGCCTGTACACCTCTT-3′, BRCA2 Exo
n19 Reverse: 5′-GCAGGCCGAGTCACTGTTAGC-3′,
BRCA2 Intron18 Reverse: 5′-TACATCTAAGAAATT
GAGCATCCT-3′, FANCL Exon6 Forward: 5′-TCACT
CTCAAGTTGAAGGCAA-3′, FANCL Exon7 Reverse:
5′-GCTTATTAAGGAGCTCTGAGGAGA-3′, FANCL
Intron6 Reverse: 5′-TGGAAACGTGGTGAATAAA
TTCT-3′, PALB2 Exon9 Forward: 5′-CCTTTCTGATC
AACAAGTAGAAGTCA-3′, PALB2 Exon10 Reverse:
5′-GGGGCATCAAAAATTGGTTT-3′, PALB2 Intro
n9 Reverse: 5′-AGTGTTGATGCGGTACATGCTTA
T-3′, Rad51 Exon6 Forward: 5′-TGAGGGTACCTTT
AGGCCAGA-3′, Rad51 Exon7 Reverse: 5′-CACTG
CCAGAGAGACCATACC-3′, Rad51 Intron6 Reverse:
5′-AGAGACATTCTTCGGCCAAACT-3′.
Clonogenic survival assays
293T orU2OS cells were transfectedwith siRNAs and incu-
bated for 62 h. Cells were then seeded as single cells at vari-
ous densities. A total of 10 h later cells were mock treated or
exposed to IR or medium containing HU, Mitomycin C or
olaparib (Sigma-Aldrich). After 7–14 days cells were fixed,
stained with crystal violet and colonies counted. Surviving
fraction for each treatment/dose was calculated by normal-
izing to plating efficiency for each siRNA treatment.
Ionizing radiation (IR)
Irradiations (IR) were carried out using an X-RAD 225 kV
X-ray generator (Precision X-ray Inc. Branford, CT, USA)
at a dose rate of 0.591 Gy.min-1.
Western blotting
Whole cell extracts were prepared by lysing cells in two vol-
umes of Lysis Buffer (250 mM NaCl, 5 mM ethylenedi-
aminetetraacetic acid (EDTA), 50 mM HEPES, 0.1% v/v
NP40). A total of 60 g of whole cell extract (WCE) was
resolved on 4–12%NOVEX gels usingMOPS buffer (Invit-
rogen). Protein was transferred to PVDF membrane (Invit-
rogen) and blotted for BCLAF1 (BTF 608A, Bethyl Labs);
THRAP3 (A300–956A, Bethyl Labs), GAPDH (ab9485,
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Abcam), pATM (S1981) (ab79891 Abcam), ATM (2C1,
Santa Cruz), pATR (S428) (2853, Cell Signaling), ATR (N-
19, Santa Cruz), 53BP1 (NB100–34, Novus Biologicals),
H2AX (S139) (JBW301, Millipore), cyclin B1 (GNS1)
(sc-245, Santa Cruz), pP53 (S15) (9284S, Cell Signal-
ing), pKAP1 (S824) (A300–767A, Bethyl Labs), FANCD2
(FI17) (sc200–22, Santa Cruz), BRCA2 (H-300) (sc-8326,
Santa Cruz), FANCL (B-11) (sc-137067, Santa Cruz),
PALB2 (H-45) (sc-382436, Santa Cruz) and Rad51 (3C10)
(sc-53428, Santa Cruz).
DNA repair assay–immunofluorescence
Cells were transfected with siRNAs and incubated for 24
h. Cells were then plated onto coverslips and incubated for
a further 24–48 h (depending on the post-treatment time
point required) before treatment with 2Gy IR using an
XRAD225X-ray generator (PrecisionX-ray Inc. Branford,
CT, USA) at a dose rate of 0.591 Gy.min-1. Cells were fixed
at 0, 1 and 24 h post-IR in 4%paraformaldehyde/phosphate
buffered saline (PBS) and then permeabilized in 0.2% Tri-
tonX-100/PBS followed by blocking in 3%BSA/PBS. Cells
were then stained with anti- -H2AX/53BP1 primary an-
tibody and anti-mouse AlexaFluor 488/568 (Invitrogen)
secondary antibody. Cells were also counterstained with
DAPI (4′,6-Diamidine-2′-phenylindole dihydrochloride)to
identify cellular nuclei. Cells containing more than 5  -
H2AX/53BP1 foci were scored and representative images
acquired using a Nikon Eclipse Ti-S fluorescence micro-
scope, with 60× objective.
RNA–FISH
Cells were transiently transfected with siRNA (siCtrl,
siTHRAP3, siBCLAF1, siTHRAP3+siBCLAF1) and left
for 48 h. Cells were further seeded onto glass coverslips
at 80% confluency and 24 h later were fixed with 4%
paraformaldehyde in PBS for 5 min at room temperature,
washed with 1× PBS for 5 min, and then left overnight in
100% ethanol at −20◦C. The next day cells were perme-
abilized for 10 min with 1× PBS containing 0.5% Triton
X-100 and washed with 1× PBS. Pre-hybridization step
was carried out for 15 min at 37◦C in pre-hybridization
buffer (2× SSC, 20% formamide, 0.2% BSA, 1 mg/ml yeast
tRNA (Sigma)). Cells were further incubated in a humidi-
fied chamber (in the dark) at 37◦C for 3 h in hybridization
buffer (pre-hybridization buffer + 10% dextran sulphate)
with oligo dT primer, after which cells were washed 2×
for 5 min in: 2× SSC/ 20% formamide at 42◦C, 2× SSC
at 42◦C, 1× SSC at RT, 1× PBS at RT. Coverslips were
mounted with ProLong Gold with DAPI. ATM specific
probe was left for incubation over night at 42◦C. The rest
of the procedure was performed as described above. The
sequences of the probes used were PolyA-fluorescence in
situ hybridization (FISH) Cy3,5′TTTTTTTTTTTTTTTT
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT3′,
ATM-FISH Cy3,5′AAAATGGGAATAGAGCAAAATA
TGTGTGAAGTAAATAGAACTTTTCTTT3′.
Cells were imaged using a Nikon-TiS fluorescence micro-
scope and for quantitative comparison of fluorescent sig-
nals the image acquisition parameters were maintained for
all acquisitions. The nuclear/cytoplasmic ratio of mRNA–
FISH fluorescent signals was measured using an in-house
developed ImageJ plugin/algorithm designed to identify
cellular nuclei from the DAPI channel of a two channel im-
age (channel 1 being DAPI and channel 2 being our fluo-
rescent RNA–FISH probe signal) and apply this as a mask
on the channel-imaged for fluorescent RNA–FISH probes
(21). The mean nuclear signal intensity was calculated by
assessing the mean pixel intensity within the nuclear mask,
which was applied from the DAPI channel, with 2 pixels
subtracted from the perimeter of the mask (to ensure that
only nuclear signal was assessed). The mean cytoplasmic
RNA–FISH signal intensity was calculated by assessing the
mean signal intensity in a 30 pixel width ring surrounding
each nucleus againwith 2 pixels subtracted from the perime-
ter of the mask to ensure only cytoplasmic signal was mea-
sured.
Immunofluorescence combined with RNA–FISH
Immunofluorescence staining was performed as described
above, albeit following this coverslips were not mounted,
but instead re-fixed in 4% paraformaldehyde in PBS for 10
min at 4◦C. Next RNA–FISH was carried out as previously
described (RNA–FISH). All the steps were performed us-
ing RNAse inhibitor (Roche) to avoid RNA degradation.
RESULTS
THRAP3 promotes resistance to DNA damage and is re-
quired for efficient DNA repair
As THRAP3 forms a part of the BRCA1/BCLAF1 com-
plex we set out to evaluate the role of THRAP3 in the
DDR in the context of BRCA1 mRNA splicing complex
function (14,15,22). Similar to BCLAF1, THRAP3 deple-
tion resulted in cellular sensitization to both double strand
breaks (IR) and stalled replication forks (HU), thus demon-
strating a role for THRAP3 in the maintenance of cellular
survival following DNA damage and suggesting an impor-
tant role within the DDR pathway (Figure 1A–C). To eval-
uate if THRAP3may play a role inDNA repair, we assessed
DNA repair kinetics in both BCLAF1- and THRAP3-
depleted cells, 0, 1 and 24 h following DNA damage. Like
BCLAF1 knockdown cells, THRAP3 depleted cells also
exhibited a significant defect in their ability to resolve  -
H2AX-marked DNA breaks 24 h after IR treatment, which
was rescued by ectopic expression of full length THRAP3
(Figure 1C–H) (14). Interestingly, deletion of either ter-
minus of THRAP3, the N-terminus containing its RNA-
binding arginine–serine (RS) domain and the C-terminus
of THRAP3 containing no known domains, lead to par-
tial restoration of cellular ability to repair IR-inducedDNA
damage (Figure 1F–H). In contrast, the central portion of
THRAP3 alone (NC) was unable to rescue this DNA
repair defect, suggesting that both termini contribute to
THRAP3s ability to mediate efficient DNA repair. More-
over, given that deletion of the N-terminal RNA-binding
domain of THRAP3 had a weaker effect in restoring the
ability of cells to repair DNA damage, it is possible that
THRAP3 is involved in the process of DNA repair predom-
inantly through its RNA-binding function (Figure 1F–H).
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Figure 1. THRAP3 mediates resistance to DNA damage and is required for efficient DNA repair and cellular survival. (A and B) Clonogenic survival
assays demonstrating that transient depletion of THRAP3 induces sensitivity to IR (A) and HU (B) in U2OS cells. Transient knockdown of BCLAF1
(siBCLAF1) was used as a positive control. Mean surviving fraction of three independent experiments is plotted ±SEM. (C) Representative western
blot demonstrating efficient THRAP3 and BCLAF1 knockdown in cells used for experiments in (A–E). (D) Representative immunofluorescent staining
of  -H2AX marked DNA damage in untreated U2OS cells transiently depleted of either BCLAF1 or THRAP3 at 1 and 24 h following 2Gy IR. (E)
Quantification of three independent experiments described above (≥200 cells were scored/experiment). Mean proportion of cells containing ≥5  -H2AX
foci is plotted ±SEM. Significant differences in the fraction of cells containing ≥5  -H2AX foci were assessed using Student’s two-tailed t-test and are
indicated by ∗∗∗P < 0.0005. (F) Schematic representation of FLAG-tagged THRAP3 constructs expressing truncated proteins used in immunofluorescent
experiments. (G) Representative immunofluorescent staining of 53BP1 marked DNA damage in U2OS cells depleted of THRAP3 (using a UTR targeted
siRNA) with further transfection of full length and truncated THRAP3 24 h following 2Gy IR. (H) Quantification of three independent experiments
described above (≥100 cells were scored/experiment). Mean proportion of cells containing ≥5 53BP1 foci is plotted ± SEM. Significant differences in the
proportion of cells containing ≥5 53BP1 foci were assessed using Student’s two-tailed t-test and are indicated by ∗P < 0.05, ∗∗P < 0.005.
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It is well known that ‘classic’ DNA repair proteins like
BRCA1, are directly recruited to the sites of DNA dam-
age where they actively participate in the DNA repair pro-
cess. In contrast, it has been shown that similar to BCLAF1
and Pinin (members of the SNARP complex), THRAP3 is
eliminated from DNA break sites induced by laser micro-
irradiation, suggesting that THRAP3 does not play a di-
rect role in DNA repair (14,15,22,23). Such exclusion might
be a reflection of transcriptional inhibition, thus resulting
in spatial suppression of RNA synthesis and the subse-
quent absence of RNA-binding proteins atDNAbreak sites
(14,15,22). However, similar proteins, such as the nuclear
RNA-binding proteins hnRNPUL 1 and 2, which also ap-
pear to be excluded from DNA break sites, have actually
been shown to be initially recruited to the sites of DNA
damage very rapidly (within 2–3 min), where they play a
role in DNA DSB end resection. This rapid and transient
recruitment of these proteins to DSBs is better visualized
when transcription is globally inhibited (24). Therefore, to
examine the possibility of the same RNA-independent lo-
calization effect for THRAP3 to DNA breaks, we treated
cells with the RNA polymerase II inhibitor 5,6-dichloro-1-
-D-ribofuranosylbenzimidazole (DRB), followed with IR
to induceDNAdamage (Supplementary Figure S1A). Inhi-
bition of transcription with DRB treatment was confirmed
by EU staining (Supplementary Figure S1B). This was car-
ried out at numerous time-points following IR (15 s, 30 s,
1 min, 2 min, 5 min, 10 min, 30 min and 1 h), however, we
did not observe any THRAP3 recruitment to DNA break
sites, even in the presence of DRB (Supplementary Figure
S1A). This suggests that like BCLAF1, THRAP3 plays an
indirect role inDNA repair andmay instead have a function
linking RNA processing/splicing and the DDR. It should
be noted that transcriptional inhibition with DRB induces
large nuclear THRAP3 foci that do not overlap with DNA
repair foci/break sites marked by  -H2AX (Supplementary
Figure S1A). These are reminiscent of stalled transcription
factories and are often seen with mRNA processing factors
at early time points following transcriptional inhibition.
Double knockdown of both THRAP3 and BCLAF1 exacer-
bates cellular sensitivity to DNA damage and DNA repair de-
ficiency
Interestingly, when performing experiments with knock-
down of either THRAP3 or BCLAF1, we have observed
that depletion of either of them leads to upregulated protein
levels of the other (Figure 1C) (25). The same compensation
in expression was also detected at the mRNA level using
qRT-PCR analysis (Figure 2A). Considering that THRAP3
and BCLAF1 share 39% identity and 66% similarity in their
primary sequences, it is perhaps not surprising that they are
able to compensate for each other at themRNAand protein
levels.
To further evaluate whether THRAP3 and BCLAF1
are able to functionally compensate for each other within
the DDR, we assessed the effect of double depletion of
THRAP3 and BCLAF1 on cellular survival and DNA re-
pair followingDNAdamage. As expected, dual knockdown
of both splicing factors led to exacerbated sensitivity of cells
to IR and HU treatment compared to depletion of either
protein alone (Figure 2B–D). This was also observed at the
DNA repair level, with the depletion of both proteins result-
ing in a repair defect comparable to that seen in BRCA1 de-
pleted cells (Figure 2E) (14). Additionally, IR-treated cells
depleted of THRAP3, BCLAF1 or both, displayedmultiple
complex chromosome aberrations in comparison to control
cells, indicating that loss of THRAP3 and BCLAF1 results
in increased genomic instability following DNA damage
(Supplementary Figure S2A and B). THRAP3/BCLAF1
co-depleted cells did not display more complex aberrations
when compared to cells depleted of THRAP3 or BCLAF1
alone. However, a large proportion of THRAP3/BCLAF1
co-depleted cell metaphase spreads were unable to be scored
due to hyperfragmentation of and/or absent chromosomes,
an indication that we have reached the limit of detection of
complex chromosome aberrations using this assay.
The cellular response to DNA damage is controlled
by two main kinase signaling cascades, the ATM-Chk2
and ATR-Chk1 pathways, which are activated by double-
and single-strand breaks respectively, thus leading to the
regulation/activation of multiple cellular processes includ-
ing DNA repair, apoptosis, transcription, cell cycle check-
point activation and RNA processing. Thereby, loss of
members of this signaling pathway can result in deregu-
lation of DDR pathways resulting in genomic instability
and/or cell death. To further investigate the severe sen-
sitivity to DNA damaging agents observed in cells de-
pleted of both THRAP3 and BCLAF1, we assessed the
activation of the canonical DDR signaling cascade within
these cells. We first examined the activation of various
mediator/effector proteins, including p53 and KAP1, by
assessing their phosphorylation by ATM/ATR following
DNA damage (Figure 2F). Interestingly, double knock-
down of THRAP3 and BCLAF1 led to loss of phospho-
rylation of both p53 and KAP1 following IR (Figure 2F).
Following this, we examined the activation of the main
upstream kinases ATM and ATR, which are responsible
for p53 and KAP1 phosphorylation following DNA dam-
age. Intriguingly, both ATMSer1981 phosphorylation and
ATRSer428 phosphorylation, were strongly downregulated
in the absence of THRAP3 and BCLAF1 following IR
treatment. However, this may be explained by the dramatic
downregulation of total expression of the ATM and ATR
proteins observed in these cells (Figure 2F). It is worth not-
ing that depletion of either BCLAF1 or THRAP3 alone ap-
peared to have a mild effect on both ATM and ATR ex-
pression, suggesting that depletion of either has some ef-
fects on ATM/ATR expression, which may be compen-
sated for by upregulation of the reciprocal protein. Inter-
estingly, the same effect i.e. loss of ATM and ATR expres-
sion was observed, even in unperturbed cells depleted of
THRAP3 and BCLAF1, thus indicating a DNA damage
and BRCA1 independent role for THRAP3 and BCLAF1
in the RNA/protein synthesis/maturation process of ATM
and ATR (Figure 2F and Supplementary Figure S2C).
Importantly, a similar repair defect to that observed in
THRAP3/BCLAF1 double depleted cells is observed upon
ATM or ATR inhibition (Supplementary Figure S2E and
F). Sensitivity to both IR and HU is highly dependent on
the status of the cell cycle, as are the levels of a number of
DDR proteins such as ATR. Therefore, we assessed cell cy-
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Figure 2. THRAP3 and BCLAF1 functionally compensate for each other. (A) THRAP3 and BCLAF1 reciprocal compensation at mRNA level. THRAP3
and BCLAF1 mRNA levels were assessed by quantitative RT-PCR in control (siCtrl) and THRAP3- or BCLAF1-depleted cells and normalized to actin
(ACTB) mRNA. Graphs represent the mean mRNA from three independent experiments ±SEM. Significance of changes was assessed using Student’s
two-tailed t-test with significant changes indicated by ∗∗P < 0.005; ∗∗∗P < 0.0005. (B and C) Clonogenic survival assays demonstrating that transient
depletion of both THRAP3 and BCLAF1 induces severe sensitivity to IR (B) and HU (C) in U2OS cells. Mean surviving fraction of three independent
experiments is plotted±SEM. (D) Representative western blot demonstrating transient depletion of THRAP3, BCLAF1 andTHRAP3/BCLAF1 inU2OS
cells used for DNA repair and clonogenic assays. (E) Quantification of three independent experiments of immunofluorescent staining of  -H2AX marked
DNA damage in untreated U2OS cells depleted of either THRAP3, BCLAF1 or THRAP3/BCLAF1, 1 and 24 h following 2Gy IR. Mean fraction of cells
containing ≥5  -H2AX foci is plotted ±SEM. Significant differences in the fraction of cells containing ≥5  -H2AX foci were assessed using Student’s
two-tailed t-test and are indicated by ∗∗∗P < 0.0005. (F) Representative western blots demonstrating loss of activation of the main downstream members
of the signaling cascade such as p53, KAP1 as result of deprivation of ATM and ATR proteins in control (siCtrl) and THRAP3, BCLAF1 and double
depleted U2OS cells following 6 Gy IR.
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cle status in THRAP3 and BCLAF1 depleted cells (Supple-
mentary Figure S2D). Importantly, depletion of THRAP3,
BCLAF1 or both did not affect cell cycle distribution in
these cells, suggesting that the sensitivity of THRAP3 and
BCLAF1 depleted cells to IR andHU is independent of the
cell cycle.
THRAP3 and BCLAF1 are involved in the maturation and
further export of transcripts encoding the ATM kinase
The generation and maintenance of a mature functional
protein requires the coordinated progression of multiple
synthesis steps such as transcription, mRNA-splicing and
export of mature mRNA from the nucleus to the cytoplasm
for translation into protein. Additionally, protein fidelity is
further maintained via regulated degradation at the end of
the functional proteins life. Thus, failure at any of these
maturation/degradation stages can result in protein loss
or dysfunction. As THRAP3 and BCLAF1 double knock-
down leads to severely downregulated levels of the ATM
protein, we next assessed their possible role in each of the
protein’s biosynthesis steps.
To examine whether ATM degradation is affected in
THRAP3/BCLAF1 depleted cells, we inhibited protein
degradation in THRAP3 and BCLAF1 single- and double
knockdown cells using the proteasome inhibitor MG132
(Supplementary Figure S3A). Interestingly, the levels of
ATM protein did not change in any of these cells follow-
ing treatment with MG132, suggesting that dual depletion
of THRAP3 and BCLAF1 does not lead to increased ATM
protein turnover and its decreased expression level is due to
dysfunction of other upstream ATM synthesis steps.
Considering our previous data showing a role for
BCLAF1 in the splicing of DDR related transcripts such
as ATRIP, BACH1 and EXO1, we next examined the lev-
els of total, post-spliced and pre-spliced ATM mRNA in
THRAP3 and BCLAF1 single- and double-depleted cells
in both unperturbed cells and following DNA damage (14)
(Figure 3A–C and Supplementary Figure S2D–M). This re-
vealed that depletion of either THRAP3, BCLAF1 or both,
leads to decreased production of the total levels of mature
spliced ATM mRNA within these cells which occurs irre-
spective of DNA damage (Figure 3A and Supplementary
Figure S4). Moreover, qRT-PCR analysis with exon–intron
targeted primers revealed a marked accumulation of pre-
splicedATM transcript within the nucleus of THRAP3 and
BCLAF1 double depleted cells, which is again independent
of DNA damage (Figure 3B). In contrast, we observed a
significant decrease in the production of the post-spliced
ATM transcript in the nucleus of these cells, confirming
that efficient splicing of ATM requires both THRAP3 and
BCLAF1 (Figure 3C and Supplementary Figure S3B). This
was observed for all exon/intron junctions assessed (Sup-
plementary Figure S2D–M). Efficiency of RNA fractiona-
tion in these experiments was confirmed by examining the
levels of the nuclear RNA,MALAT1 (Supplementary Fig-
ure S3B). Interestingly, BCLAF1 depletion was shown to
have amore obvious effect onATM splicing thanTHRAP3,
suggesting a more dominant role for BCLAF1 in this pro-
cess (Figure 3B and C).
To further verify this, we generated anmRNA splicing re-
porter construct containing an exon–intron–exon sequence
from ATM (exon20–exon21) flanked either side by two flu-
orescent tags, RFP and GFP. Importantly, the intronic se-
quence between exons 20 and 21 contains an in-frame stop
codon, which, if left unspliced, will result in truncation
of the encoded protein and expression of RFP but not
GFP from this construct (Figure 3D). As such, the ratio of
GFP/RFP expression can be used to assess ATM exon20–
21 splicing efficiency in vivo. Based on this, we utilized high-
content imaging of cells transfected with this construct to
assess GFP/RFP fluorescence intensity. Initially, to assess
the functionality of this reporter system, we assessed the
GFP/RFP expression ratio in HEK 293T cells transfected
with this construct and either mock treated or treated with
the splicing inhibitor Spliceostatin A (SSA) (26). As ex-
pected, the GFP/RFP signal ratio i.e. splicing efficiency
was diminished following SSA treatment (Supplementary
Figure S3C). Using this splicing reporter assay, we found
that knockdown of BCLAF1, in contrast to THRAP3, re-
sulted in a marked downregulation of ATM splicing, but
not GAPDH splicing, confirming that BCLAF1 plays the
predominant role in ATM splicing (Figure 3E). Interest-
ingly, in comparison to single depleted cells, double knock-
down of THRAP3 and BCLAF1 led to a slight reduction in
ATM splicing, even when compared to BCLAF1 depletion
alone, suggesting that both THRAP3 and BCLAF1 func-
tion together and/or within the same pathway to regulate
ATM mRNA splicing (Figure 3C and E).
Previous studies have suggested that THRAP3 may play
a role in mRNA export, a process tightly and sequen-
tially linked with mRNA splicing and required for the sta-
bility of mature mRNAs (25). Given that we observed
a slight decrease in ATM splicing in THRAP3 depleted
cells, as well as additional downregulation of ATM splic-
ing followed by THRAP3 co-depletion with BCLAF1, we
next examined the impact of THRAP3 knockdown on the
nuclear-cytoplasmic distribution of poly(A) mRNA and
more specifically ATM mRNAs, using RNA–FISH with
an oligo(dT) or ATM specific probes (Figure 4A and B).
The nuclear/cytoplasmic ratio of poly(A) mRNA fluores-
cent signal was measured using an image analysis algo-
rithm designed to quantify the mean nuclear and cytoplas-
mic pixel intensity (Supplementary Figure S5A). In control
siRNA-treated cells, the poly(A) RNA signal was equally
distributed between the nucleus and cytoplasm. In contrast,
THRAP3 depletion caused the poly(A) RNA species to
accumulate in the nucleus, with a concomitant reduction
in the cytoplasm (Figure 4A and B). Moreover, export of
the poly(A) RNA pool was rescued by ectopic expression
of full length THRAP3, suggesting that THRAP3 is re-
quired for the efficient transport of mRNAs from the nu-
cleus to the cytosol (Figure 4C and D). Interestingly, ex-
pression of either THRAP3 truncation construct, lacking
either the N- or C-terminus (N and C) was unable to
rescue the nuclear accumulation of poly(A) mRNAs, albeit
both N and C THRAP3 appeared to have a partial im-
pact on mRNA export (Figure 4C and D), consistent with
their ability to partially rescue DNA repair (Figure 1G and
H). Taken together this emphasises the importance of both
THRAP3 termini, i.e. the RNA-binding domain and the
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Figure 3. Depletion of THRAP3 and BCLAF1 results in deficient processing of transcripts encoding the ATM kinase. (A) Expression level of total post-
spliced ATM mRNA in control (siCtrl) and THRAP3 (siTHRAP3), BCLAF1 (siBCLAF1) and double depleted cells (siTHRAP3/siBCLAF1). Primers
were designed within exons 20–21 spanning intron 20. mRNA expression was assessed via qRT-PCR on cDNA generated from DNAse treated RNA
samples and normalized toACTBmRNA levels in the same sample. Graphs represent themean normalized expression from three independent experiments
±SEM. Significance of changes was assessed using Student’s two-tailed t-test with significant changes indicated by ∗∗P < 0.005; ∗∗∗P < 0.0005. (B and C)
Nuclear expression levels of pre-spliced (exon 20–intron 20) (B) and post-spliced (exon 20–exon 21) (C) ATM mRNAs in nuclear extracts from control
(siCtrl), THRAP3 (siTHRAP3), BCLAF1 (siBCLAF1) and double depleted (siTHRAP3/siBCLAF1) cells. mRNA expression was assessed via qRT-
PCR on cDNA generated from DNAse treated RNA samples and normalized to ACTB mRNA levels in the same sample. Graphs represent the mean
normalized expression from three independent experiments ±SEM. Significance of changes was assessed using Student’s two-tailed t-test with significant
changes indicated by ∗P < 0.05; ∗∗P < 0.005; ∗∗∗P < 0.0005. (D) Schematic representation of an mRNA splicing reporter construct containing either an
exon–intron–exon sequence from ATM (exon 20–exon 21) flanked either side by two fluorescent tags, RFP and GFP or an exon–intron–exon sequence
from GAPDH (exon 3–exon 4). The intronic sequence between ATM exons 20 and 21 (intron 20) and GAPDH exons 3 and 4 (intron 3) contain in-frame
stop codons, which when unspliced will result in truncation of the encoded protein and expression of RFP but not GFP from this construct. However,
efficient ATM/GAPDH splicing will result in expression of both RFP and GFP from their respective constructs. A construct containing spliced ATM
exon20–21 was also used as a positive control. (E) Quantification of splicing reporter assays usingATM andGAPDH splicing reporter constructs described
above in control (siCtrl) and THRAP3, BCLAF1 and double knockdown 293T cells. A total of 10 000 cells were scored per experiment. Graphs represent
the mean GFP/RFP signal ratio from three independent experiments ±SEM. Significance of changes was assessed using Student’s two-tailed t-test with
significant changes indicated by ∗∗P < 0.005; ∗∗∗P < 0.0005.
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Figure 4. THRAP3 and BCLAF1 are involved in nuclear export of ATM transcripts. (A) Representative polyARNA–FISH showing nuclear accumulation
of poly(A) RNA in THRAP3, BCLAF1 and double depleted U2OS cells 72 h post-transfection with appropriate siRNA in the absence and following
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/45/22/12816/4588108 by U
niversity of Edinburgh user on 01 O
ctober 2018
12826 Nucleic Acids Research, 2017, Vol. 45, No. 22
N-terminus, which shares some homology with BCLAF1,
in the process of RNA export. Loss of BCLAF1 also im-
pacts poly(A) RNA export, but to a far lesser extent than
THRAP3 (Figure 4A and B). However, given the role of
BCLAF1 in the splicing of DDR related transcripts, a pre-
requisite for mRNA export, this is perhaps not surprising.
In keeping with this, double depletion of THRAP3 and
BCLAF1 does not lead to increased nuclear retention of the
poly(A) RNA pool, in comparison to THRAP3 depletion
alone, thus indicating a predominant role for THRAP3 in
the export of BCLAF1/THRAP3 co-regulated targets and
suggesting the deficient splicing and export of a large range
of transcripts in these cells (Figure 4A and B).
More specifically, depletion of THRAP3 caused nuclear
retention of ATM transcripts, suggesting that THRAP3
does indeed promote ATM mRNA export (Figure 4E and
F). Furthermore, the accumulation of ATM mRNA ob-
served in THRAP3 deficient cells is not due to increased
decay of ATM transcripts in these cells (Supplementary
Figure S5B). Moreover, the absence of both THRAP3 and
BCLAF1 resulted in nuclear accumulation ofATMmRNA
in nuclear speckles reminiscent of pre-mRNA processing
and splicing factories, thus confirming the defective pro-
cessing of these transcripts in these cells (Figure 4E and F).
Taken together, these data suggest that BCLAF1 has a dom-
inant role in the splicing of ATM, whereas THRAP3 is pre-
dominantly responsible for its export from the nucleus to
the cytoplasm.
THRAP3 and BCLAF1 double knockdown leads to impaired
splicing and export of DDR transcripts
Although it is clear that THRAP3 and BCLAF1 coor-
dinate the processing of ATM transcripts, it is also clear
from our poly(A) RNA FISH experiments that loss of
THRAP3 and/or BCLAF1 has a more profound effect on
a larger pool of poly-adenylated RNAs. Therefore, in or-
der to identify additional transcripts regulated by THRAP3
and BCLAF1 we performed micro-array based gene ex-
pression analysis of nuclear and cytoplasmic RNA pools in
THRAP3 and BCLAF1 co-depleted cells. Because mRNA
splicing and export are linked processes, we reasoned that
cytoplasmic mRNA expression would be affected by loss of
both of these steps. First, the efficiency of RNA fractiona-
tion was confirmed by examining the levels of the nuclear
RNA, MALAT1 (Supplementary Figure S6A). Following
this, cytoplasmic and nuclear RNA pools were hybridized
to human whole-transcriptome micro-arrays. Three repli-
cates were performed, allowing the identification of genes
with significant changes in expression following THRAP3,
BCLAF1 and THRAP3/BCLAF1 depletion (false dis-
covery rate (FDR)-adjusted P-value < 0.01). To identify
genes whose splicing/export was regulated by THRAP3
and BCLAF1 we filtered for genes downregulated in the
cytoplasmic fraction by more than 1.5-fold (Supplemen-
tary Figure S6B). In THRAP3 depleted cells 849 genes
were downregulated, versus 749 genes downregulated in
BCLAF1 depleted cells. Of these genes, only 191 (13.6%)
were downregulated in both THRAP3 and BCLAF1 de-
pleted cells (Supplementary Figure S6C). Functional an-
notation of these genes using DAVID (v6.7) found only
small groups of genes involved in multiple cellular path-
ways including DNA-binding/chromatin structure, cellu-
lar glycoproteins, membrane signalling proteins, cytoskele-
ton structure, etc. In contrast, the abundance of 2538 cy-
toplasmic RNAs (9.6% of the 26 501 examined) were sig-
nificantly reduced in the double depleted samples (P <
0.05), suggesting a degree of selectivity in how THRAP3
and BCLAF1 regulate mRNA splicing and export. Intrigu-
ingly, only 84 of these genes overlapped with those regu-
lated by both THRAP3 or BCLAF1 alone (Supplemen-
tary Figure S6D). Functional annotation of these 84 genes
revealed that the vast majority encode DNA-binding pro-
teins involved in chromatin structure, including a number
of histone variants as well as a small number of DNA-
binding transcription factors. However, we reasoned that,
due to their ability to functionally compensate for each
other, targets of BCLAF1 and THRAP3 mediated splicing
and export, such as ATM, are likely to be most noticeably
downregulated when both proteins are absent, i.e. the 2538
genes specifically downregulated in THRAP3 andBCLAF1
double depleted cells (Supplementary Figure S6D). In-
deed, functional annotation of genes downregulated in the
cytoplasmic fraction of THRAP3/BCLAF1 co-depleted
cells using DAVID (v6.7) revealed that the largest three
gene ontology groups regulated by THRAP3/BCLAF1 are
genes involved in transcriptional regulation (385 genes),
cell cycle regulation/cell division (241 genes) and DNA
Damage/DNA Repair (127 genes). The finding that 385
genes involved in transcriptional regulationwere downregu-
lated in THRAP3/BCLAF1 double depleted cells suggests
that downregulation of these genes themselves may have
secondary/downstream effects on their own target genes.
However, given that THRAP3/BCLAF1 have only been
transiently depleted for a short period of time (in these cells
using siRNA, it is unclear to what extent these secondary
effects may impact these results). Nonetheless, and perhaps
most strikingly, mRNAs encoding the vast majority of the
proteins involved in the Fanconi Anaemia (FA) pathway
and essential HR factors were downregulated in the cyto-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
treatment with IR (6 Gy, 1 h). (B) Quantification of nuclear/cytoplasmic ratio of poly(A) RNA fluorescent signal in control, and THRAP3, BCLAF1
and double depleted cells using the described scoring algorithm of three independent experiments. Significant differences in the ratios were assessed using
Student’s two-tailed t-test and are indicated by ∗P < 0.05; ∗∗P < 0.001. (C) Representative immunofluorescence followed by poly(A) RNA–FISH in
THRAP3 depleted U2OS cells transfected with THRAP3-FL, N and C constructs 72 h post-transfection. (D) Quantification of nuclear/cytoplasmic
ratio of poly(A) RNA fluorescent signal in control and THRAP3 depleted cells transfected with different truncated constructs using scoring algorithm of
three independent experiments. Significant differences in the ratios were assessed using Student’s two-tailed t-test and are indicated by ∗P < 0.05; ∗∗P <
0.005. (E) Representative RNA–FISH with the ATM specific probe showing nuclear accumulation of ATM mRNA in THRAP3, BCLAF1 and double
depleted U2OS cells in the absence and following treatment with IR (6 Gy, 1 h). (F) Quantification of nuclear/cytoplasmic ratio of fluorescent signal in
(E) was performed using scoring algorithm in three independent experiments. Significant differences in the ratios were assessed using Student’s two-tailed
t-test and are indicated by ∗P < 0.05.
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plasmic pool of THRAP3 and BCLAF1 depleted cells, po-
tentially explaining the severe DNA repair defect observed
in these cells.
These findings prompted us to examine the effect of
THRAP3 and BCLAF1 depletion on the processing and
nuclear export of key downregulated transcripts encod-
ing FA and HR proteins. Indeed, qRT-PCR analysis of
pre-spliced RNAs from THRAP3 and BCLAF1 depleted
cells shows that unspliced transcripts encoding FANCD2,
BRCA2, FANCL and RAD51 accumulate in these cells
(Figure 5A and Supplementary Figure S7A). In contrast,
the level of post-spliced transcripts encoding these genes
is remarkably reduced, thus indicating the importance of
BCLAF1 and THRAP3 in the processing of these tran-
scripts (Figure 5B and Supplementary Figure S7B). Expres-
sion of pre- and post-spliced PALB2 (a core HR gene indi-
cated as unchanged in the micro-array data) and GAPDH
mRNAs, used as negative controls, remained unaltered
(Figure 5A and B; Supplementary Figure S7A and B),
thus revealing the selectivity of BCLAF1 and THRAP3
for specific target genes. Moreover, FANCL, BRCA2,
FANCD2 and RAD51 mRNAs detected by qRT-PCR ac-
cumulate in the nucleus following THRAP3/BCLAF1 de-
pletion, in contrast toPALB2 andGAPDHmRNAs, whose
nuclear/cytoplasmic distribution is unchanged (Figure 5C).
Consistent with this, the reduced splicing and export of
BRCA2, RAD51, FANCD2 and FANCL observed in these
cells results in their downregulated protein expression in
the absence of THRAP3 and BCLAF1 in both untreated
and IR treated cells (Figure 5D). As expected, the levels
of PALB2 and GAPDH proteins remain unaltered (Figure
5D).
To functionally assess the effect of THRAP3 and
BCLAF1 depletion on the FA/HR pathways, we examined
the ability of THRAP3/BCLAF1 knockdown cells to form
FANCD2 foci, a hallmark of a functional FA pathway, fol-
lowing MMC treatment (Supplementary Figure S7C and
D). As predicted, double knockdown cells displayed a fail-
ure to form FANCD2 foci, thus contributing to the severe
sensitivity of double depleted cells to DNA damage.
The interplay between FA and HR pathways in DNA re-
pair is well characterized. Where FA cells are generally sen-
sitive to inter-strand crosslink (ICL)-inducing agents such
as cisplatin and MMC they are not sensitive to poly(ADP-
ribose) polymerase (PARP) inhibitors, which specifically
target HR defective cells. In contrast, cells with mutations
in key HR genes e.g. FANCD1/BRCA2, FANCN/PALB2,
FANCR/RAD51 and FANCS/BRCA1 are notably hyper-
sensitive to PARP inhibitors (27,28). Given that depletion
of THRAP3 and BCLAF1 leads to loss of both core FA
genes and HR genes, we hypothesised that cells depleted of
BCLAF1 and THRAP3 would be sensitive to both ICL-
inducing agents and PARP inhibition. Indeed, depletion of
BCLAF1 and THRAP3 induced a marked sensitivity to
both MMC (an ICL-inducing agent) and the PARPi Ola-
parib (Figure 5E and F).
To further assess HR efficiency in THRAP3/BCLAF1
depleted cells, we directly assessed HR using a GFP, HR
reporter cell line. This cell line harbors the commonly used
DR-GFP reporter cassette, which contains two mutant ver-
sions of the GFP gene; one with two internal stop codons
and an internal I-Sce I restriction site (SceGFP), the other
with both 3′ and 5′ truncations (iGFP). Neither SceGFP
nor iGFP encode a functional GFP protein; however, fol-
lowing induction of a DSB at the I-Sce I restriction site,
HR mediated repair leads to a gene conversion event re-
sulting in the generation of a functional GFP gene. As a re-
sult, nuclear GFP expression represents a quantifiable read-
out of HR function. Using this reporter, single depletion
of THRAP3 or BCLAF1 led to a marked decrease in GFP
protein expression (Figure 5G). As observed before, deple-
tion of both THRAP3 and BCLAF1 further exacerbated
this HR deficiency, suggesting that both processing factors
are essential for HR and that again these factors function-
ally compensate for each other to promote the processing
of HR promoting transcripts (Figure 5G). Interestingly, the
effect of THRAP3/BCLAF1 co-depletion is similar to loss
of BRCA1, a key HR protein directly involved in DSB re-
section, emphasizing the importance of processing/export
of DDR related transcripts by THRAP3/BCLAF1 (Figure
5G).
Our findings collectively suggest a mechanism whereby
the THRAP3 and BCLAF1 proteins work at the level of
mRNA splicing and nuclear mRNA export to selectively
control the expression of a subset of DDR transcripts,
thereby promoting efficient HR mediated repair and repair
of DNA ICLs. Intriguingly, recent work by Wickramas-
inghe et al. has shown that ALY, an RNA-binding compo-
nent of the THO/TREX complex that couples RNA tran-
scription to processing andmRNA export, regulates the nu-
clear export of a similar but distinct pool of transcripts in-
volved in the maintenance of genomic stability (29). This
study showed that ALY promotes the nuclear export of
these transcripts in response to phosphatidy-linositol (3-
5)-trisphosphate (PIP3) production, regulated by the inos-
itol polyphosphate multikinase (IPMK). Additionally, this
study found that recognition and export of ALY target tran-
scripts is mediated through the binding of ALY to a con-
served GAGGCTGGGG RNA-binding sequence within
the 3′ untranslated region (UTR) of target transcripts. Ad-
ditionally, a recent study examining the RNA-binding mo-
tif within ALY found that it does not bind RNAs through
its conserved RNA recognition motif (RRM) but instead
binds transcripts through a conserved WxHD motif found
within its N-terminus. Intriguingly, this study found the
same conserved RNA-binding motif within both THRAP3
and BCLAF1, suggesting that they may regulate similar
target genes and/or bind similar RNA-binding sequences
within target transcripts. To test this, we performedMEME
(v.4.11.2) analysis of the 3′ UTR of all 2538 genes identified
as THRAP3/BCLAF1 target genes through our microar-
ray analysis, to identify over-represented motifs of 6–12
nt in length. This identified two distinct significantly over-
represented degenerate 12-mermotifs within the 3′ UTRs of
these transcripts (Figure 5H). Wickramasinghe et al. iden-
tified two highly similar motifs within ALY regulated tar-
get genes, however, only the GAGGCTGGGG motif was
found to bind ALY. Given that motif-2 identified within our
BCLAF1/THRAP3 target genes represents a highly identi-
cal binding sequence, GGAGGCTGGGGC and given that
both THRAP3 andALY contain the same conservedRNA-
binding motif, it is likely that THRAP3 also recognizes its
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Figure 5. THRAP3 and BCLAF1 double knockdown leads to impaired splicing and export of DDR transcripts. (A and B) Expression levels of (A) pre-
spliced BRCA2 (Exon 18–Intron 18), FANCD2 (Exon 36–Intron 36), FANCL (Exon 6–Intron 6), RAD51 (Exon 6–Intron 6), PALB2 (Exon 9–Intron 9) and
GAPDH (Exon 3–Intron 3) mRNAs and (B) post-spliced BRCA2 (Exon 18-Exon 19), FANCD2 (Exon 36-Exon 37), FANCL (Exon 6-Exon 7), RAD51
(Exon 6-Exon 7), PALB2 (Exon 9-Exon 10) and GAPDH (Exon 3–Exon 4) mRNAs. Expression was assessed via qRT-PCR on cDNA generated from
DNAse treated nuclear RNA extracts and normalized to ACTB levels in the same sample. Graphs represent the mean of three independent experiments
±SEM. Significance of changes was assessed using Student’s two-tailed t-test with significant changes indicated by ∗∗P < 0.005; ∗∗∗P < 0.0005. (C)
Nuclear/cytoplasmic ratio of FANCD2, FANCL, RAD51, PALB2 and GAPDHmRNA. Expression was assessed via qRT-PCR on cDNA generated from
DNAse treated RNA samples and normalized to ACTB. Efficiency of nuclear and cytoplasmic RNA extracts was confirmed via qRT-PCR for MALAT1.
Graphs represent the mean of three independent experiments ±SEM. Significant differences in the ratios were assessed using Student’s two-tailed t-test
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target transcripts through binding to this sequence. It is pos-
sible that THRAP3 and ALY interact to form part of the
same RNA-binding/regulatory complex, however, we were
unable to detect an interaction between THRAP3 and ALY
suggesting that they indeed regulate this overlapping group
of transcripts independently (Supplementary Figure S7E).
THRAP3 cancer associated mutations lead to defective DNA
repair and export of THRAP3 target transcripts
Evidence that the BRCA1/BCLAF1 splicing complex
may carry out an essential tumor suppressor function
arises from the identification of cancer driver mutations
within members of the complex, such as BRCA1, SF3B1,
U2AF1/2, etc. We therefore set out to assess the im-
pact of the two most common cancer associated muta-
tions within THRAP3, C301>T (R101*) and C2509>T
(R837*) (identified through the catalog of somatic muta-
tions in cancer (cancer.sanger.ac.uk)) on THRAP3 function
(30). The C301>T mutation results in the introduction of a
stop codon thereby producing a 101 aa protein, possessing
only two-third of the THRAP3 RS domain. Similarly, the
C2509>T variant also results in the introduction of a stop
codon and encodes an 837 aa protein that lacks only the end
of the C-terminus, in comparison to the full-length 955 aa
THRAP3 protein. Both mutations were found in multiple
cancers suggesting that they may function as cancer driver
mutations.
THRAP3 constructs were generated by cloning the hu-
man THRAP3 coding region in frame with N-terminal myc
and FLAG tags. Using site directed mutagenesis, the afore-
mentioned mutations were then introduced into this con-
struct. To examine the effect of these mutations (R101*
and R837*) on cellular DNA repair and their potential role
in cancer development, U2OS cells, which express endoge-
nous wild-type (wt)-THRAP3, were transfected with wt or
mutant THRAP3 constructs and cellular DNA repair ca-
pacity assessed, thus mimicking the heterozygous nature of
these mutations in cancer cells (Figure 6A). Both THRAP3
cancer-associated mutations affected cellular ability to re-
pair DNA DSBs 24 h after treatment, in comparison to
control cells transfected with wt THRAP3, thus mirror-
ing our previous results, which demonstrated that both
the N-terminal RS domain and the C-terminal region of
THRAP3 are required for efficient DNA repair (Figure
6A and B). In a similar manner, we also examined the ca-
pacity of the R101* and R837* mutant THRAP3 to pro-
mote the export of THRAP3-dependent transcripts, such
as ATM, BRCA2, FANCD2, FANCL and RAD51. Im-
portantly, both THRAP3 cancer associated mutants con-
fered an mRNA export defect, similar to that observed
in THRAP3-depleted cells, leading to defects in mRNA
distribution and its accumulation within the nucleus (Fig-
ure 6C). Additionally, the nuclear/cytoplasmic ratios of
PALB2 and GAPDH transcripts, which are not exported
by THRAP3, remained unaltered upon mutant THRAP3
expression (Figure 6C). Given that mutant THRAP3 was
expressed in a wt THRAP3 background, in both of these
assays, this data suggest that mutant THRAP3 functions
in a dominant negative manor, thus abrogating normal cel-
lular DNA repair capacity and potentially contributing to
cancer development.
DISCUSSION
Recent findings from our group, as well as others, have im-
plicated the RNA processing machinery in the regulation
of the cellular DDR. Consistent with this and in addition
to their role in the BRCA1/BCLAF1 mRNA splicing com-
plex previously described by our group, here we demon-
strate that BCLAF1 and THRAP3 also contribute to the
DDR through novel RNA processing functions, which are
independent of both DNA damage and BRCA1 (Figure 7).
Despite the fact that we did not observe any differential reg-
ulation of HR/FA genes regulated by THRAP3/BCLAF1
in response to DNA damage, it is possible that regula-
tion of THRAP3/BCLAF1 following DNA damage e.g.
the phosphorylation and/or PARylation events previously
reported for these proteins (15,16,31), may fine tune their
mRNA splicing/export functions in response to different
types and/or levels of genotoxic stimuli.
Within this study, we also found that BCLAF1 and
THRAP3 function together to promote the splicing and
mRNA export of target genes, with BCLAF1 playing a pre-
dominant role in splicing, whereas THRAP3 plays a more
dominant role in mRNA export. Despite the seemingly dis-
tinct roles in RNA processing, depletion of BCLAF1 does
indeed have an impact on mRNA export and vice versa, de-
pletion of THRAP3 has a slight impact on mRNA splicing
(Figure 7). However, given the tightly linked nature of these
two processes, this is perhaps not surprising, as mRNA
splicing is required for mRNA export and may indeed re-
sult in the formation of export complexes onto spliced tran-
scripts (9,32). Additionally, it is likely that lack of mRNA
export i.e. the removal of spliced transcripts from transcrip-
tion factories, impinges on mRNA splicing. Indeed, a num-
ber of biochemical studies have shown that down regula-
tion of mRNA export can directly impact mRNA splicing
competence (2). Our study also found that the downregula-
tion of mRNA splicing and export of BCLAF1/THRAP3
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
and are indicated by ∗P < 0.05; ∗∗P < 0.005; ∗∗∗P < 0.0005. (D) Representative western blots demonstrating reduced protein expression levels of BRCA2,
FANCD2, FANCL and RAD51 in control (siCtrl) and THRAP3/BCLAF1 double depleted cells either untreated or treated with IR (6 Gy 1 h). Protein
levels of PALB2 and GAPDH were used as a positive control. (E and F) Clonogenic survival assays in control (siCtrl), THRAP3, BCLAF1 and double
depleted 293T cells following treatment with mitomycin C (MMC) (E) and Olaparib (F). Mean cell viability of three independent experiments is plotted
±SEM. (G) Quantification of the DR-GFP reporter assay in control (siCtrl) and BRCA1, THRAP3, BCLAF1, double knockdownU2OS cells. 10 000 cells
were scored per experiment using high-content imaging.Graphs represent themeanGFP signal from three independent experiments±SEM. Significance of
changes was assessed using Student’s two-tailed t-test with significant changes indicated by ∗P < 0.05, ∗∗P < 0.001. (H) Overrepresented motifs of lengths
8–20 nt from the 3′ UTR regions of transcripts downregulated in the cytoplasm of THRAP3/BCLAF1 double depleted cells were determined using
Multiple Em (expectation maximization) for Motif Elicitation (MEME). Two overrepresented 12-mer motifs in the 3′ UTR of the transcripts identified
are indicated.
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Figure 6. Defect in DNA damage repair and RNA export in THRAP3
associated mutants. (A) Representative immunofluorescent staining of
53BP1 marked DNA damage in U2OS cells depleted of THRAP3 with
further transfection of THRAP3 cancer associated mutants 24 h following
2Gy IR. (B) Quantification of three independent experiments described
above (≥100 cells were scored/experiment). Mean fraction of cells con-
taining ≥5 53BP1 foci is plotted ±SEM. Significant differences in the
fraction of cells containing ≥5 53BP1 foci were assessed using Student’s
two-tailed t-test and are indicated by ∗∗P < 0.005, ∗∗∗P < 0.0005. (C)
Nuclear/cytoplasmic ratio of ATM, BRCA2, FANCD2, FANCL, RAD51,
PALB2 and GAPDH mRNA levels in control (siCtrl) and THRAP3 de-
pleted cells as well as in cells expressing THRAP3 cancer associated muta-
tions R101* and R837* was quantified by qRT-PCR in three independent
experiments. Graphs represent the mean mRNA expression levels relative
to control from three independent experiments ±SEM.
target genes in cells depleted of these proteins lead to al-
most complete loss of their encoded proteins, whereas sin-
gle depletion of THRAP3 and BCLAF1 had only a mild
effect on many of these proteins. In keeping with this, we
found that depletion of either THRAP3 or BCLAF1 alone,
lead to upregulated transcription and subsequent expres-
sion of the other protein e.g. BCLAF1 knockdown lead
to increased THRAP3 expression. This suggests that the
splicing function of BCLAF1 and the export function of
THRAP3 are, at least in part, redundant functions and can
in some way be compensated for by upregulation of the re-
ciprocal protein/function. It is possible that BCLAF1 up-
regulation in the absence of THRAP3 serves to increase the
concentration of spliced THRAP3/BCLAF1 target genes
thereby saturating mRNA processing factories with these
transcripts and facilitating the export of these transcripts
via other export proteins/adapters, e.g. ALY. Similarly, the
upregulation of THRAP3 in the absence of BCLAF1 may
serve to increase the export of THRAP3/BCLAF1 target
genes that may be spliced, albeit less efficiently, by other
mRNA splicing components. However, more work will be
required to understand this complex process, which may
require gene/transcript specific models beyond the scope
of this study. Additionally, although we have shown that
THRAP3 and BCLAF1 compensation occurs at the tran-
scriptional level, the mechanism through which this occurs
requires further investigation. It may be that THRAP3 and
BCLAF1 co-regulate themselves at the splicing and export
level. Alternatively, they may co-regulate the levels of tran-
scription factors that regulate the expression of each other.
Indeed, a number of transcription factors e.g. E2F’s, iden-
tified as THRAP3/BCLAF1 target genes in this study, do
indeed bind the promoters of THRAP3 and BCLAF1 di-
rectly (33).
Given that many of the genes regulated by
THRAP3/BCLAF1 encode proteins within the HR/ICL
repair pathway, it is not surprising that THRAP3 and
BCLAF1 depletion lead to decreased HR activity and cel-
lular sensitivity to both the ICL inducing agent mitomycin
C and the PARP inhibitor, olaparib, which is known to
target HR deficient cells. Intriguingly, as described earlier,
the mRNA export of an overlapping but distinct set of
genes has been reported to be regulated by ALY, an RNA-
binding protein that functions to couple transcriptional
processing and mRNA export (29). ALY itself is recruited
to mRNP particles during/coincident with splicing, form-
ing at nuclear speckle structures, which are accumulation
sites for mRNA maturation factors (8). ALY then recruits
the export receptor protein TAP, which mediates the export
of mRNAs. THRAP3, also forms nuclear speckles, which
are characterized by their increase in size and intensity
following transcriptional inhibition (34) (Supplementary
Figure S1A) and has also been shown to bind TAP (20),
suggesting that it may function in a similar fashion to ALY.
Intriguingly, a recent study has found that ALY does not
selectively bind transcripts through its RRM, but instead
this occurs through two highly conserved WxHD and
HDxR motifs (35). These motifs were also found within
THRAP3, supporting the hypothesis that THRAP3 may
function in a similar fashion to ALY and may indeed
bind to, and regulate, similar transcripts (35). In support
of this, we also found similar 3′ UTR-binding sequences
within THRAP3 regulated transcripts, albeit the motifs
we have identified are slightly longer than those identified
within ALY target transcripts (ALY recognition motif =
10-mer GAGGCTGGGG versus THRAP3 recognition
motifs = 12-mer GGAGGCTGGGGC) (29). Nevertheless,
it is clear that THRAP3 and ALY function distinctly to
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Figure 7. Model of THRAP3 andBCLAF1 function. In normal cells BCLAF1 andTHRAP3 function together to promote the selective splicing (BCLAF1)
and mRNA export (THRAP3) of a subset of genes, many of which are involved within the cellular DDR pathway. Loss of both BCLAF1 and THRAP3
results in defective splicing and export with subsequent loss of protein expression of THRAP3/BCLAF1 regulated genes. In contrast, in the absence of
THRAP3, BCLAF1 is upregulated, which although confers some DDR deficiency, at least partially compensates for THRAP3 loss, presumably via an
increased capacity to splice target transcripts which may be exported by alternative, less specific/efficient export proteins. Similarly, loss of BCLAF1 results
in upregulation of THRAP3, resulting in increased capacity for export of BCLAF1/THRAP3 target genes, which may be spliced by less specific/efficient
splicing proteins, which is able to partially compensate for loss of BCLAF1, resulting in a mild DDR defect.
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regulate discrete pools of transcripts. Indeed, ALY has
been shown to play a more global role in the regulation of a
large pool of transcripts, which is regulated by the binding
of phosphatidy- linositol (3-5)-trisphosphate (PIP3), the
levels of which are controlled by IPMK (29). ALY has been
shown to directly bind PIP3, through a series of conserved
arginine and lysine residues within its N-terminus (36),
suggesting that PIP3 binding may alter ALYs structure,
thereby regulating its ability to bind and selectively regulate
HR-related transcripts. In contrast, THRAP3 does not
appear to contain a similar PIP3-binding region/residues
and therefore it is unlikely that IPMK/ PIP3 regulate its
ability to bind to and regulate target transcripts.
Given the role of THRAP3/BCLAF1 in the regula-
tion of DDR proteins, we hypothesized that some cancer-
associated mutations within THRAP3, particularly those
that result in loss of THRAP3 structure/function, may con-
fer a DNA repair defect on cells harboring these muta-
tions. To examine this we tested the impact of two cancer-
associated mutations R101* and R837* on THRAP3 func-
tion. Ectopic expression of either THRAP3 mutant, even
in a THRAP3 wt background, resulted in downregulated
export of key THRAP3/BCLAF1 target genes involved
in HR and ICL repair and a subsequent defect in cel-
lular DSB repair, which was similar to that observed in
THRAP3 depleted cells. This suggests that THRAP3 trun-
cationmutants function in a dominant negativemanner, po-
tentially suggesting that THRAP3 may function within a
complex requiringmore than one intact THRAP3molecule
and/or that mutant THRAP3 prevents export of target
transcripts by wt THRAP3. Taken together, this data sug-
gests that patients with tumors harboring truncating muta-
tions in THRAP3, or other mutations that result in loss of
THRAP3 protein expression/function, may respond better
to DNA damaging chemotherapies, radiotherapy and tar-
geted therapies, such as PARPi’s, that target tumors with
an intrinsic DNA repair defect.
In conclusion, this study highlights the multifunctional
nature of the RNA processing factors THRAP3 and
BCLAF1 in the selective splicing and export of a large
subset of transcripts involved in the cellular DDR. More-
over, as cancer associated mutations within THRAP3 re-
sult in deregulated export of target transcripts and a
subsequent DNA repair defect, this data suggests that
THRAP3/BCLAF1may function to suppress tumor devel-
opment and/or act as biomarkers of response to therapy.
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